Drug profile · INN
isocarboxazid
MARPLAN
isocarboxazid (MARPLAN) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — isocarboxazid
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
isocarboxazid (MARPLAN) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Monoamine oxidase inhibitor
Primary target: Monoamine oxidase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is isocarboxazid?
isocarboxazid (MARPLAN) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for isocarboxazid?
MARPLAN is a marketed brand name for isocarboxazid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of isocarboxazid?
isocarboxazid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.